Skip to content
Review

Bio-inspired adaptive nanoparticles: from adaptive regulation to cancer drug delivery and therapy.

Sep 2026 · Materials Horizons · 0 citations · 155 references
Medicine

TL;DR

This Review summarizes recent advances in bio-inspired adaptive nanoparticles for cancer applications and discusses the major challenges and future directions for developing next-generation adaptive nanomedicines with translational potential.

Abstract

Living systems, including cells and viruses, exhibit intrinsic adaptivity that enables them to navigate complex biological environments through dynamic regulation of their structural and functional states. Inspired by these natural processes, bio-inspired adaptive nanoparticles have emerged as a promising strategy to overcome the limitations of static nanocarriers. These engineered systems sense or recognize changes in the local microenvironment and subsequently undergo spatiotemporal remodeling of their structures, biointerfaces, or biological functions, thereby meeting stage-specific requirements for cancer delivery and therapy. In this Review, we summarize recent advances in bio-inspired adaptive nanoparticles for cancer applications. We first outline representative natural adaptive particles and their underlying adaptive mechanisms. We then discuss how these principles guide the design of structurally and functionally adaptive nanoparticles to overcome tumor-delivery barriers and regulate the tumor microenvironment. Finally, we highlight approaches for the mechanistic and quantitative validation of adaptive behavior and discuss the major challenges and future directions for developing next-generation adaptive nanomedicines with translational potential.

View source

Similar papers

Review Open access Oct 2026

Nanoparticle-Based Drug Delivery Systems for Anticancer Therapy: Microenvironment-Driven Strategies, Advances, and Challenges

Cancer remains a major global health challenge, and nanoparticle-based drug delivery systems have emerged as a promising strategy for targeted cancer therapy. However, clinical translation is still limited by an incomplete understanding of how nanoparticles navigate the tumor microenvironment (TME) throughout the deliv...

Meng-Xin Ban, Si-Fang Zhao, Zi-Yu Liu et al. · 0 citations
Review Open access Sep 2026

Cancer Drug Delivery with Nanoparticles and Biomolecules: Stimuli-Responsive, Theranostic, and AI-Guided Approaches

This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...

C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al. · 0 citations
Review Open access Sep 2026

Engineering and Precision Delivery Strategies of Functionalized Extracellular Vesicles for Antitumor Therapy

Nanomedicine harnesses the unique benefits of nanocarriers to markedly enhance drugs targeting tumors, which is becoming a promising approach to achieve precise and effective antitumor therapy. Extracellular vesicles (EVs), natural nanoscale entities, have garnered extensive attention due to their high biocompatibility...

Xuan-Han Zhang, Xiao-Wei Zhou, S. Fu et al. · 0 citations
Review Open access Sep 2026

Breaking Biological Barriers: Engineering Nanocarriers for Efficient Drug and Gene Delivery through Nano-Bio Interfaces and Biophysical Design

A persistent challenge in nanomedicine is achieving functional delivery of therapeutic molecules across physiological barriers. Organs impose distinct transport constraints, including the blood–brain barrier, renal filtration, hepatic sequestration, and pulmonary clearance. Although substantial effort has focused on en...

Zi-Cheng Deng, A. Dunn, Daniel Q. Sun et al. · 0 citations
Review Open access Oct 2026

Stimuli-Responsive Nanocarriers in Oncology: Tumor Microenvironment Triggers, Overcoming Biological Barriers, and Clinical Reality

Conventional anticancer nano-therapies often rely on passive accumulation through the enhanced permeability and retention (EPR) effect, resulting in insufficient penetration of tumor tissue and heterogeneous cellular uptake. Smart nanocarriers that are able to respond to specific stimuli through conformational, charge-...

Di-Pu Pan, Shubhajit Sarkar, Souvik Adhikary et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.